Medinox, Inc. and Orient Europharma Co., Ltd. Announce Collaboration on Developing NOX-100, a New Anti-Hypotensive Drug
4/12/2010 9:05:46 AM
More...
|
Medinox, Inc. Announces Clinical Results of Naproxen Prodrug
5/27/2009 8:45:02 AM
More...
|
Medinox, Inc. Appoints George Ko To Board Of Directors
10/19/2005 5:12:22 PM
More...
|
Medinox, Inc. And PUMC Pharmaceutical Co., Ltd. Agree To Collaborate On Developing NOX-100 Septic Shock Drug In China And South Korea
10/19/2005 5:11:09 PM
More...
|
Medinox, Inc. Announces The Presentation Of NOX-100 Septic Shock Clinical Results At The Sixth World Congress On Trauma, Inflammation, Shock And Sepsis In Munich, Germany On March 3, 2004.
10/19/2005 5:10:21 PM
More...
|
Medinox, Inc. Discloses A Potential New Drug For The Treatment Of Sickle Cell Disease In A Paper Published In The British Journal Of Haematology
10/19/2005 5:10:06 PM
More...
|